Breast cancer cells with high metastatic potential, such as MDA-MB-231 cells, are characterized by greater ATP release and P2Y2 receptor (P2Y2R) activity relative to less-metastatic cells. The gene discussed is P2RY2; the disease is breast carcinoma.